Neuprex rBPI: XOMA's international Phase III trial of Neuprex

Xoma Corp. (XOMA), Berkeley, Calif. Product: Neuprex rBPI.21 Indication: Treat meningococcemia Status: XOMA's international Phase III trial of Neuprex in 300-350 pediatric patients with meningococcemi...